Melanoma

Optimizing Outcomes For Patients With Lung Cancer: Checkpoint Inhibitor Therapy in NSCLC, Patient Coaching, and Evaluation of Patient Reported Outcomes

Optimizing Outcomes For Patients With Lung Cancer: Checkpoint Inhibitor Therapy in NSCLC, Patient Coaching, and Evaluation of Patient Reported Outcomes

Lung cancer remains the leading cause of cancer death among both men and w…

Expiration Date: 8/16/2021

Max Credits: 1

View Activity

Checkpoint Inhibitors as First-line Treatments for Lung Cancer: What You Need to Know

Checkpoint Inhibitors as First-line Treatments for Lung Cancer: What You Need to Know

Lung cancer remains the leading cause of cancer death among both men and w…

Expiration Date: 6/29/2021

Max Credits: 1

View Activity

Clinical Advances and Emerging Trends in Melanoma: A Symposium at the Society for Melanoma Research 2019 Congress

Clinical Advances and Emerging Trends in Melanoma: A Symposium at the Society for Melanoma Research 2019 Congress

In this educational activity, experts in the field review the patient, dis…

Expiration Date: 3/18/2021

Max Credits: 0.75

View Activity

Melanoma—BRAF-Mutated Disease, Checkpoint Inhibitors, Emerging Trends, and Challenging Cases

Melanoma—BRAF-Mutated Disease, Checkpoint Inhibitors, Emerging Trends, and Challenging Cases

In this educational activity, experts in the field review the patient, dis…

Expiration Date: 3/16/2021

Max Credits: 2.25

View Activity

The Latest on the Checkpoint Inhibitor Revolution in Advanced Melanoma: Focus on Long-term Outcomes and Brain Metastases

The Latest on the Checkpoint Inhibitor Revolution in Advanced Melanoma: Focus on Long-term Outcomes and Brain Metastases

For patients diagnosed with metastatic melanoma, the lifetime incidence of…

Expiration Date: 4/30/2020

Max Credits: 0

View Activity

GameOn! Test Your Confidence Regarding Immune Checkpoint Inhibition for Cancer Management

GameOn! Test Your Confidence Regarding Immune Checkpoint Inhibition for Cancer Management

The integration of immune checkpoint inhibitors into treatment strategies …

Expiration Date: 2/23/2018

Max Credits: 0

View Activity

Combination Strategies in Melanoma Management: What's New and What's Next

Combination Strategies in Melanoma Management: What's New and What's Next

Melanoma is the sixth most common cancer in the United States and the dead…

Expiration Date: 1/23/2018

Max Credits: 0

View Activity

Emerging Trends in the Sequencing and Combination of Therapies for Advanced Melanoma

Emerging Trends in the Sequencing and Combination of Therapies for Advanced Melanoma

Melanoma is the sixth most common cancer in the United States, and the num…

Expiration Date: 9/23/2017

Max Credits: 0

View Activity

Optimizing the Use of Targeted Therapy in Advanced Melanoma: Where We Are and Where We Are Going

Optimizing the Use of Targeted Therapy in Advanced Melanoma: Where We Are and Where We Are Going

Melanoma is the deadliest form of skin cancer. Historically, treatment opt…

Expiration Date: 2/25/2017

Max Credits: 0

View Activity

Optimizing the Use of Targeted Therapy in Advanced Melanoma: Where We Are and Where We Are Going

Optimizing the Use of Targeted Therapy in Advanced Melanoma: Where We Are and Where We Are Going

Melanoma is the deadliest form of skin cancer. Historically, treatment opt…

Expiration Date: 2/25/2017

Max Credits: 0

View Activity